36 related articles for article (PubMed ID: 8591903)
21. Management of Herpes Simplex Virus Keratitis in the Pediatric Population.
Vadoothker S; Andrews L; Jeng BH; Levin MR
Pediatr Infect Dis J; 2018 Sep; 37(9):949-951. PubMed ID: 29794647
[TBL] [Abstract][Full Text] [Related]
22. Evidence-based treatment of herpes simplex virus keratitis: a systematic review.
Guess S; Stone DU; Chodosh J
Ocul Surf; 2007 Jul; 5(3):240-50. PubMed ID: 17660897
[TBL] [Abstract][Full Text] [Related]
23. Herpes simplex keratitis.
Hill GM; Ku ES; Dwarakanathan S
Dis Mon; 2014 Jun; 60(6):239-46. PubMed ID: 24906668
[No Abstract] [Full Text] [Related]
24. Towards a selective chemotherapy of virus infections. Development of bromovinyldeoxyuridine as a highly potent and selective antiherpetic drug.
De Clercq E
Verh K Acad Geneeskd Belg; 1986; 48(4):261-90. PubMed ID: 3024419
[No Abstract] [Full Text] [Related]
25. Brivudine: a herpes virostatic with rapid antiviral activity and once-daily dosing.
Rabasseda X
Drugs Today (Barc); 2003 May; 39(5):359-71. PubMed ID: 12861349
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
Maudgal PC; De Clercq E; Huyghe P
Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
[TBL] [Abstract][Full Text] [Related]
27. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
De Clercq E
Med Res Rev; 2005 Jan; 25(1):1-20. PubMed ID: 15389733
[TBL] [Abstract][Full Text] [Related]
28. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
de Clercq E
Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
[No Abstract] [Full Text] [Related]
29. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.
De Clercq E
Biochem Pharmacol; 2004 Dec; 68(12):2301-15. PubMed ID: 15548377
[TBL] [Abstract][Full Text] [Related]
30. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis.
Kaufman HE; Haw WH
Curr Eye Res; 2012 Jul; 37(7):654-60. PubMed ID: 22607463
[TBL] [Abstract][Full Text] [Related]
31. The development of BVDU: An odyssey.
De Clercq E
Antivir Chem Chemother; 2023; 31():20402066231152971. PubMed ID: 36710501
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
